Project Grant R16HD116702

Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $155K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Washington, DC 20059, USA
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $725,628 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct clinical studies investigating the use of the Bionic Pancreas in pregnancy. The research aims to optimize settings for the Ilet Bionic Pancreas device to achieve pregnancy-specific...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop and test an implementation protocol for early detection of gestational diabetes mellitus (GDM) in high-risk pregnant women. The $163,039 grant will fund a pilot randomized controlled trial to assess the feasibility and acceptability of a first-trimester GDM screening protocol using serum...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $601,499 to The Trustees of the University of Pennsylvania to study the role of maternal obesity and extracellular vesicles (EVs) in altering mitochondrial function and metabolic programming in offspring. The research aims to determine how obesity during pregnancy increases the secretion of...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to investigate the relationship between maternal pancreas growth during pregnancy and the development of diabetes. The $2,468,757 award to the University of Texas at Austin will fund a longitudinal study using magnetic resonance imaging (MRI) to measure maternal and fetal pancreas size,...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $234,000.00 to Oregon Health & Science University (OHSU) to conduct research on the impact of maternal obesity on metabolic and immune function in offspring. The key research aims are to: 1) conduct a pre-clinical trial using low-dose aspirin in pregnant mice to assess its potential to reduce...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $1,538,070 to the Regents of the University of Minnesota to study the role of mitochondrial nutrient transport in regulating trophoblast differentiation. The research aims to reveal novel, nutrient-responsive mechanisms controlling epigenetic and transcriptional reprogramming events foundational to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $585,232 to Brigham & Women's Hospital Inc. to conduct research on the neurobiobehavioral underpinnings of intergenerational obesity. The award period runs from Aug 15, 2024 to May 31, 2029. The research will involve two complementary studies: 1) a secondary analysis of a pre-birth cohort to determine the...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,007,897 to Yale University to conduct research on the impact of the CREBRF genetic variant on the risk of gestational diabetes (GDM) and postpartum type 2 diabetes (T2DM) in American Samoan women. The research aims to examine how the CREBRF variant influences glucose homeostasis during...
This $829,637 Project Grant awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to determine the effectiveness of real-time continuous glucose monitoring (CGM) at reducing maternal and neonatal morbidity and mortality in pregnant individuals with type 2 diabetes. The research will define adequate glycemic control targets for CGM and self-monitoring of blood glucose, and identify social...
This federal Project Grant award, totaling $456,251.00, was provided by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The overarching goal of the proposed research is to test the hypothesis that pro-inflammatory mediators produced by maternal adipose tissue (leptin) reduce pro-angiogenic immune cells and factors at the maternal-fetal interface, which can contribute to adverse pregnancy outcomes...

ROLES OF PLACENTAL MITOCHONDRIA IN THE VICIOUS CYCLE OF DIABETES AND PREGNANCY - PROPOSAL ABSTRACT TYPE II DIABETES MELLITUS (T2D) WITH INCREASING PREVALENCE REPRESENTS A MAJOR BURDEN FOR HEALTH AND CARE SYSTEM AND INDIVIDUALS. HOWEVER, THE ROOT CAUSE OF T2D HAS NOT BEEN UNDERSTOOD COMPLETELY. RECENT HUMAN EPIDEMIOLOGICAL STUDIES INDICATE THAT GESTATIONAL DIABETES MELLITUS (GDM) PREDISPOSES TYPE 2 DIABETES (T2D) AND OTHER METABOLIC DISEASES IN OFFSPRING, RESULTING IN A VICIOUS CYCLE OF DIABETES AND PREGNANCY TRANSGENERATIONALLY. THEREFORE, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASES (DOHAD) MAY PROVIDE A NEW ANGLE IN THE STUDIES OF METABOLIC DISEASES INCLUDING T2D. THE DUAL ROLES OF BNIP3 IN MEDIATING MITOPHAGY AND LIPID METABOLISM SUGGEST THAT THE DELETION OF BNIP3 IN TROPHOBLAST CELLS IS EXPECTED TO IMPAIR PLACENTAL MITOCHONDRIAL FUNCTION, LIPID CATABOLISM, AND THUS, NEGATIVELY AFFECTING MATERNAL METABOLIC ADAPTATIONS TO PREGNANCY AND LEADING TO THE DEVELOPMENT OF GDM. WE PROPOSE THAT BNIP3 MAY PLAY A CRITICAL ROLE IN THE PROCESS OF PLACENTAL DEVELOPMENT AND CONSEQUENT PROGRAMMING OF T2D IN OFFSPRING. IN THIS APPLICATION, WE HYPOTHESIZE THAT BNIP3 MEDIATED PLACENTAL MITOPHAGY PLAYS A CRITICAL ROLE IN THE DEVELOPMENT OF GDM AND TROPHOBLAST SPECIFIC KNOCKOUT OF BNIP3 IN PREGNANT MICE WILL CAUSE MATERNAL GDM AND PREDISPOSE T2D IN OFFSPRING THROUGH PLACENTAL PROGRAMMING. CONTINUING OUR PREVIOUS STUDY, WE WILL CONFIRM THE IMPAIRED PLACENTAL MITOPHAGY IN GDM WOMEN WHICH IS MEDIATED BY BNIP3 (AIM 1), THEN WE WILL INVESTIGATE THE ROLE OF BNIP3 DEPENDENT MITOPHAGY PATHWAY IN THE DEVELOPMENT OF GDM IN A MOUSE MODEL WITH TROPHOBLAST SPECIFIC KNOCKOUT OF BNIP3 (AIM 2). USING THIS UNIQUE MOUSE GDM MODEL, WE WILL INVESTIGATE THE ONSET AND PROGRESSION OF T2D IN OFFSPRING (AIM 3). TAKEN TOGETHER, THE PROPOSED STUDIES, FOR THE FIRST TIME, MODEL THE VICIOUS CYCLE BETWEEN MATERNAL GDM AND GDM PREDISPOSED ADULT METABOLIC DISEASES BY MANIPULATING THE PLACENTAL MITOPHAGY BUT NOT INTERFERING WITH OTHER MATERNAL ORGANS, AND THUS, PROVIDING POWERFUL PLATFORM IN THE MECHANISTIC STUDIES ON GDM AND T2D, HELPING DEVELOP NOVEL MEANS FOR THE PREVENTION AND TREATMENT OF THESE DISEASES, AND BREAKING THE VICIOUS CYCLE OF DIABETES AND PREGNANCY.

Posted 6/24/24, 12:00 AM